Posted on 8/6/20
Amnon Gavish Joins MyMedicalShopper as EVP of Corporate Development and Strategy
Dr. Amnon Gavish, an entrepreneur, digital health executive, and thought leader with decades of experience in technology and strategy development, has joined MyMedicalShopper as Executive Vice . . .
Posted on 8/6/20
Fractyl Raises $55 Million in Series E Financing
Fractyl Laboratories Inc. (Fractyl), a life sciences company dedicated to novel therapeutic interventions that can reverse the metabolic disease epidemic, today announced a first close of . . .
Posted on 8/6/20
eMaxx Appoints Eileen Currie to Lead Insurance Operations
PEABODY, Mass.--(BUSINESS WIRE)--eMaxx, a leading commercial property and casualty InsurTech, today announced that Eileen Currie has been appointed President / CEO of eMaxx’s insurance operating companies. . . .
Posted on 8/6/20
Road to Responsibility Receives PPE Donation from MEMA
Road to Responsibility (RTR), one of the region’s largest and most successful non-profit organizations dedicated to serving individuals with intellectual and developmental disabilities, recently received a . . .
Posted on 8/6/20
Habitat for Humanity of Greater Plymouth Extends COVID-19 Rent Relief Program
Habitat for Humanity of Greater Plymouth (HFHGP) has announced a Phase Two extension of their COVID-19 Rent Relief program. Originally launched in mid-June, the organization has . . .
Posted on 8/6/20
InnovHeart Appoints J. Brent Ratz as Chief Executive Officer and Member of the Board
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation,
Posted on 8/6/20
Prof. Angus Dalgleish Joins ViralClear’s Scientific Advisory Board
BioSig Technologies, Inc.’s (Nasdaq: BSGM) subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), today announced the addition of Professor Angus Dalgleish
Posted on 8/6/20
States Whose Weekly Unemployment Claims Are Recovering the Quickest – Updated WalletHub Study
Despite recent spikes in COVID-19, new unemployment claims decreased week-over-week on July 27, and were still 83% below the peak during the COVID-19 pandemic. To help . . .
Posted on 8/6/20
Aerovate Therapeutics Emerges From RA Capital Incubator With $72.6 Million Funding
Aerovate Therapeutics, Inc., has closed on $72.6 million in Series A funding to advance trials of AV-101, an inhaled, dry powder aerosol version of imatinib
Posted on 8/6/20
The First SmartFlowers In Boston Bloom At Assembly Row
Creating Visible Connections Between Solar Energy & Artistic ExpressionSmartFlower Solar, the Boston-based solar company behind the award-winning Smartflower, introduced its first multi-unit Smartflower installation in Massachusetts . . .
Posted on 8/6/20
DICK'S Sporting Goods Announces Grand Opening of 11 Stores in Nine States in August
DICK'S Sporting Goods (NYSE: DKS), the largest U.S.-based, omni-channel sporting goods retailer, will expand its nationwide footprint with the opening of four DICK'S Sporting Goods stores, . . .
Posted on 8/6/20
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
As all aspects of healthcare continue to evolve amidst the COVID-19 pandemic, there remains an opportunity for companies to provide an integrated approach across the health . . .
Posted on 8/6/20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2020, which reflect strong product sales, continued advancement of the pipeline and . . .
Posted on 8/6/20
Tangen Biosciences Closes $12.2M Series B Financing
Tangen Biosciences, Inc., a molecular diagnostic company located in Branford, Connecticut, announced that it has closed a $12.2 million Series B Preferred Stock financing
Posted on 8/6/20
Houghton Mifflin Harcourt Announces Second Quarter 2020 Results
Learning company Houghton Mifflin Harcourt (Nasdaq: HMHC) today announced financial results for the quarter ended June 30, 2020. Nationwide COVID-19-related school closings continued to impact second quarter . . .
Posted on 8/6/20
Agenus Provides R&D Update & Second Quarter Financial Report
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers . . .
Posted on 8/6/20
Synlogic Reports Second Quarter 2020 Financial Results and Provides Business Update
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the second quarter ended . . .
Posted on 8/6/20
Iron Mountain Reports Second Quarter 2020 Results
Iron Mountain Incorporated (NYSE: IRM), the storage and information management services company, announces financial and operating results for the second quarter of 2020. The conference call . . .
Posted on 8/6/20
Alnylam Announces Planned Transition of Barry Greene, President
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that after 17 years, Barry Greene, President,
Posted on 8/6/20
Global Partners Reports Second-Quarter 2020 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) today reported financial results for the quarter ended June 30, 2020.“We delivered strong results in the second quarter, reflecting . . .
Posted on 8/6/20
J.Jill Announces Extended Forbearance
QUINCY, Mass.--(BUSINESS WIRE)--J.Jill, Inc. (NYSE JILL), today announced that the Company and its lenders have further amended the Company’s existing Forbearance Agreements, dated as of June . . .
Posted on 8/6/20
Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported first quarter fiscal 2021 revenue of $164.9 million compared to . . .
Posted on 8/6/20
AVROBIO Reports Second Quarter 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported financial . . .
Posted on 8/6/20
Concert Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Company Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2020.“We continue to be committed to advancing both of our . . .
Posted on 8/6/20
Dicerna Announces Second Quarter 2020 Financial Results and Provides a Business Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today reported its financial results for the second quarter . . .

